Skip to content

ReposiTrak TRAK Proceeds From Warrant Exercises

Proceeds From Warrant Exercises at other companies

BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$6.25K
Upexi logo
UpexiUPXI
$92.11K
Richtech Robotics Inc. logo
Richtech Robotics Inc.RR
$9.18M+126%
NextNav logo
NextNavNN
$13K-97.5%
OS Therapies logo
OS TherapiesOSTX
$722.22K
Airship AI Holdings, Inc. logo
Airship AI Holdings, Inc.AISP
$10-100.0%

Other financials

Income statement

See full
Revenue$5.9M-0.5%
Gross profit$4.7M+11.1%
Operating income$1.6M+23.9%
Net income$2.0M+13.8%
EPS (diluted)$0.09+20.7%

Balance sheet

See full
Cash & equivalents$26.4M-6.1%
Total debt$349.5K-55.1%
Total equity$50.5M+3.2%
Total assets$57.4M+4.6%

Cash flow

See full
Operating cash flow$2.1M+45.2%
CapEx$11.8K
Free cash flow$2.1M+46.1%

Valuation

See full
Market cap$163.56M-54.8%
Enterprise value$137.5M-58.9%
P/E22.6×-29.3×
P/S-9.1×

Profitability

See full
Gross margin83.7%+0.4pp
Operating margin27.5%+3.0pp
Net margin30.8%+0.3pp
FCF margin31.9%-7.8pp

Returns & leverage

See full
Return on equity14.6%+0.5pp
Debt / equity0.0×
Current ratio4.9×-1.1×

Where this comes from

Reported directly by ReposiTrak in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.

The official record: ReposiTrak’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about ReposiTrak's proceeds from warrant exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ReposiTrak's proceeds from warrant exercises?
ReposiTrak (TRAK) reported proceeds from warrant exercises of $0 in Q1 2026.
How has ReposiTrak's proceeds from warrant exercises changed year-over-year?
ReposiTrak's proceeds from warrant exercises decreased by 100.0% year-over-year, from $19.78K to $0.
What does proceeds from warrant exercises mean?
This metric represents the cash inflows received by the company when holders of warrants exercise their right to purchase common stock at a predetermined price. It indicates the conversion of derivative instruments into equity, which strengthens the company's capital base. Investors analyze this to understand potential dilution and the influx of capital from existing financial commitments.